MedPath

Effect of hematopoietic growth factors therapy on brain injury

Not Applicable
Recruiting
Conditions
Diseases of the circulatory system
Registration Number
KCT0008633
Lead Sponsor
Yonsei University Health System, Severance Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

In terms of subject selection criteria, the following conditions apply: 1) Adults aged 19 and above who are capable of providing voluntary consent, 2) Individuals with brain injuries occurring after the acute phase (one week after brain injury) such as ischemic brain injury, hypoxic-ischemic brain injury, hemorrhagic brain injury 3) Individuals who, according to the attending physician, are clinically eligible for re-enrollment in the study at least 6 months after the last hematopoietic growth factor injection.

Exclusion Criteria

The exclusion criteria for the subjects are as follows: 1) Individuals under the age of 19 who are incapable of providing voluntary consent, 2) Presence of cerebral lesions such as tumors or infections, 3) Use of anticoagulant warfarin (coumadin) (excluding medications from the antiplatelet drug class), 4) Leukopenia, thrombocytopenia, polycythemia, 5) History of malignant disease or myeloproliferative disorders, 6) Septic embolism, malignant hypertension, hyperkalemia, 7) Hepatic or renal dysfunction; serum creatinine > 3 mg/dl, 8) Allergy to erythropoietin or G-CSF medications, 9) Exclusion criteria for MRI examination, 10) Pregnant or breastfeeding women, 11) Body temperature above 38 degrees Celsius, presence of pneumonia on chest radiography, 12) Recurrent pneumonia symptoms, 13) Blood pressure exceeding 140/90 mmHg despite the use of antihypertensive medications, 14) Hemoglobin levels exceeding 15 g/dL. Individuals meeting any of these criteria will be excluded from the target group.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Systolic Blood Pressure;Diastolic Blood Pressure;Pulse Rate;Complete Blood Test;Erythropoietin;CD34+
Secondary Outcome Measures
NameTimeMethod
Manual Muscle Testing;Rang of Motion;Modified Ashworth Scale;Modified Barthel index;Functional independence measure;Grip and Pinch Power;Box and Block Test;Jebsen Taylor Hand Function Test
© Copyright 2025. All Rights Reserved by MedPath